ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2,1,Failure to thrive,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
2,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
3,1,Hypertrichosis,Hypertrichoses,Skin appendage conditions,Skin,N
4,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
4,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
5,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
6,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
6,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
7,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
7,2,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
8,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
8,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
8,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
8,4,Headache,Headaches NEC,Headaches,Nerv,N
8,5,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
8,6,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
8,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
8,8,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
9,1,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
10,1,Glycosuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
10,2,Ketosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
11,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
12,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
13,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
14,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
14,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
14,3,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
15,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
16,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
17,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
18,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
19,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
19,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
20,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
21,1,Cerebrovascular disorder,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
22,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
23,1,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
24,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
25,1,Coma,Coma states,Neurological disorders NEC,Nerv,Y
25,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
26,1,Goitre,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
27,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
28,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
29,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
30,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
31,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
32,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
33,1,Hypertrichosis,Hypertrichoses,Skin appendage conditions,Skin,N
34,1,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
35,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
35,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
36,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,Y
37,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
37,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
37,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
38,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
39,1,Ileus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
40,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
41,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
41,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
42,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
43,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
43,2,Paresis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
44,1,Hypertrichosis,Hypertrichoses,Skin appendage conditions,Skin,N
44,2,Virilism,Female gonadal function disorders,Endocrine disorders of gonadal function,Endo,N
45,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
46,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
47,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
48,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
48,2,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
49,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
50,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
51,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
51,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
51,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
51,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
52,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
53,1,Right ventricular failure,Right ventricular failures,Heart failures,Card,N
54,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
55,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
55,2,Gravitational oedema,Oedema NEC,General system disorders NEC,Genrl,N
55,3,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
55,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
55,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
55,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
55,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
56,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
56,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
57,1,Rectal tenesmus,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
58,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
59,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
59,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
59,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
59,4,Poor feeding infant,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
59,5,Regurgitation,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
59,6,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
60,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
61,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
61,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
62,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,Y
63,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
63,2,Hypertrichosis,Hypertrichoses,Skin appendage conditions,Skin,N
64,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
64,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
65,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
66,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
67,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
67,2,Necrotising colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
68,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
68,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
69,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
69,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
69,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
70,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
71,1,Hyperglycaemic hyperosmolar nonketotic syndrome,Diabetic complications neurological,Diabetic complications,Metab,N
72,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
73,1,Necrotising enterocolitis neonatal,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,Y
74,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
74,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
75,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
76,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
76,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
76,3,Therapeutic product effect increased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
77,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
78,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
79,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
79,2,Hypertrichosis,Hypertrichoses,Skin appendage conditions,Skin,N
79,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
80,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
80,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
80,3,Poor feeding infant,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
80,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
81,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
81,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
82,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
82,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
82,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
83,1,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
83,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
84,1,Necrotising colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
85,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
85,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
85,3,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
85,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
86,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
87,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
87,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
88,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
89,1,Hypertrichosis,Hypertrichoses,Skin appendage conditions,Skin,N
89,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
90,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
91,1,Hypertrichosis,Hypertrichoses,Skin appendage conditions,Skin,N
92,1,Necrotising enterocolitis neonatal,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
92,2,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
93,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
93,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
94,1,Gastroenteritis viral,Viral infections NEC,Viral infectious disorders,Infec,N
94,2,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
95,1,Hypertrichosis,Hypertrichoses,Skin appendage conditions,Skin,N
96,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
96,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
96,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
96,4,Hypertrichosis,Hypertrichoses,Skin appendage conditions,Skin,N
96,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
97,1,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
98,1,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
99,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
100,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
101,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
102,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
103,1,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
104,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
104,2,Drug tolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
105,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
106,1,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
107,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
107,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
107,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
107,4,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
108,1,Ileus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
109,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
109,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
110,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
110,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
110,3,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
110,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
110,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
111,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
111,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
111,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
112,1,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
113,1,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
114,1,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
115,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
115,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
116,1,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,Y
117,1,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
118,1,Hypertrichosis,Hypertrichoses,Skin appendage conditions,Skin,N
119,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
119,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
119,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
119,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
119,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
120,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
121,1,Headache,Headaches NEC,Headaches,Nerv,N
121,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
121,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
121,4,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
121,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
122,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
123,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
